Jesse E. Merten Sells 40,102 Shares of The Allstate Co. (NYSE:ALL) Stock

The Allstate Co. (NYSE:ALL) CFO Jesse E. Merten sold 40,102 shares of Allstate stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the transaction, the chief financial officer now owns 18,115 shares of the company’s stock, valued at $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Allstate Stock Performance

Shares of NYSE:ALL opened at $192.97 on Friday. The business has a 50-day moving average of $191.46 and a two-hundred day moving average of $189.48. The firm has a market capitalization of $51.10 billion, a PE ratio of 11.36, a P/E/G ratio of 1.47 and a beta of 0.52. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The Allstate Co. has a 12 month low of $153.87 and a 12 month high of $209.88.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. As a group, research analysts forecast that The Allstate Co. will post 18.64 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Barclays cut their price target on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a report on Monday, January 6th. The Goldman Sachs Group boosted their target price on shares of Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a research note on Friday, November 15th. BMO Capital Markets raised their price target on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Jefferies Financial Group boosted their price objective on shares of Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Finally, Bank of America upped their price objective on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $217.94.

Hedge Funds Weigh In On Allstate

Hedge funds and other institutional investors have recently made changes to their positions in the business. VSM Wealth Advisory LLC purchased a new position in Allstate in the fourth quarter valued at about $25,000. FSA Wealth Management LLC purchased a new stake in shares of Allstate during the 3rd quarter valued at about $26,000. Twin Tree Management LP acquired a new position in Allstate during the 4th quarter worth approximately $27,000. Northwest Investment Counselors LLC purchased a new position in Allstate in the 3rd quarter worth approximately $28,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in Allstate in the third quarter valued at approximately $29,000. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.